Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Exp Dermatol ; 29(2): 190-195, 2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-29660185

RESUMEN

Central centrifugal cicatricial alopecia (CCCA) has an unknown mechanism. Analyzing other scarring diseases (lichen planopilaris, fibrotic kidney disease and scleroderma) may help to clarify the mechanism of scarring in CCCA. These diseases were chosen for comparison due to either their location of disease (skin or scalp specifically), or prominence in patients of African descent. Genetics, possible triggers, an autoimmune lymphocytic response, and epithelial to mesenchymal transition are potentially involved. Possible common pathways in scarring diseases and a better understanding of the CCCA mechanism will lead to further research into the pathogenesis and potential treatments of CCCA.


Asunto(s)
Alopecia/etiología , Alopecia/patología , Cicatriz/etiología , Enfermedades Renales/etiología , Liquen Plano/etiología , Esclerodermia Sistémica/etiología , Cicatriz/patología , Fibrosis/etiología , Humanos , Riñón/patología , Enfermedades Renales/patología , Liquen Plano/metabolismo , PPAR gamma/metabolismo , Cuero Cabelludo
3.
Dermatitis ; 32(2): 101-110, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33273226

RESUMEN

BACKGROUND: Hair products are a potential cause of allergic contact dermatitis. There are limited data on the allergen content of ethnic hair products. OBJECTIVE: To identify allergens unique to ethnic hair products (shampoos, conditioners, styling products) and provide a resource for low allergen hair care products for patients with ethnic hair types. METHODS: The top 100 best-selling shampoos, conditioners, and styling products for ethnic and nonethnic hair products were determined from 3 major online retailers (Walmart, Target, Walgreens). Allergen was defined as presence on the 2017 American Contact Dermatitis Society Core 80 allergen list. RESULTS: The 2017 American Contact Dermatitis Society Core 80 allergens were tabulated for ethnic and nonethnic shampoos, conditioners, and styling products. A list of low-allergen shampoos, conditioners, and styling products was identified. Fragrance was the most common allergen for ethnic shampoos, conditioners, and styling products. Other notable allergens included methylchloroisothiazolinone/methylisothiazolinone, formaldehyde releasers, cetyl steryl alcohol, tocopherol, decyl glucoside, sodium benzoate, and phenoxyethanol. CONCLUSIONS: This study identifies important differences in allergens found in products marketed for ethnic hair compared with those marketed for nonethnic hair.


Asunto(s)
Dermatitis Alérgica por Contacto , Fármacos Dermatológicos/efectos adversos , Preparaciones para el Cabello/administración & dosificación , Preparaciones para el Cabello/química , Alérgenos , Dermatitis Alérgica por Contacto/etiología , Etnicidad , Humanos
4.
J Clin Transl Sci ; 5(1): e134, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34367678

RESUMEN

INTRODUCTION: Barriers to research participation by racial and ethnic minority group members are multi-factorial, stem from historical social injustices and occur at participant, research team, and research process levels. The informed consent procedure is a key component of the research process and represents an opportunity to address these barriers. This manuscript describes the development of the Strengthening Translational Research in Diverse Enrollment (STRIDE) intervention, which aims to improve research participation by individuals from underrepresented groups. METHODS: We used a community-engaged approach to develop an integrated, culturally, and literacy-sensitive, multi-component intervention that addresses barriers to research participation during the informed consent process. This approach involved having Community Investigators participate in intervention development activities and using community engagement studios and other methods to get feedback from community members on intervention components. RESULTS: The STRIDE intervention has three components: a simulation-based training program directed toward clinical study research assistants that emphasizes cultural competency and communication skills for assisting in the informed consent process, an electronic consent (eConsent) framework designed to improve health-related research material comprehension and relevance, and a "storytelling" intervention in which prior research participants from diverse backgrounds share their experiences delivered via video vignettes during the consent process. CONCLUSIONS: The community engaged development approach resulted in a multi-component intervention that addresses known barriers to research participation and can be integrated into the consent process of research studies. Results of an ongoing study will determine its effectiveness at increasing diversity among research participants.

5.
J Dermatolog Treat ; 29(3): 238-240, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-28789575

RESUMEN

INTRODUCTION: Atopic dermatitis (AD) is a common, chronic inflammatory skin disease characterized by pruritic, often lichenified, patches and plaques. METHODS: Data were obtained from the Humana database, a large claim-based database encompassing more than 20 million patients under a commercial healthcare insurance plan. Our cohort included 39,526 subjects who saw a dermatologist for a primary ICD-9 diagnosis of atopic dermatitis (691.8) between the years of 2010 and 2015. Subjects were stratified according to gender, age and race. Prescribed medication lists were obtained and sorted based on potential indication for atopic dermatitis. RESULTS: The most common medications prescribed for atopic dermatitis in descending order were topical corticosteroids (60.2% of patients), oral antibiotics (17.3% of patients), antifungals (6.7% of patients), antihistamines (6.4% of patients), oral corticosteroids (5.9% of patients), calcineurin inhibitors (2.3% of patients) and emollients (1.2% of patients). Males ages 20-39 and 40-59 had the highest rates of oral steroids prescribed, at 9.2% and 9.8% of patients, respectively. CONCLUSIONS: Presumably, individuals who are prescribed multiple courses of oral corticosteroids over time have severe atopic dermatitis with recalcitrance to other options. Given the side effect profile of oral corticosteroids, steroid-sparing systemic agents may be a better long-term option in the absence of contraindications.


Asunto(s)
Corticoesteroides/uso terapéutico , Dermatitis Atópica/tratamiento farmacológico , Fármacos Dermatológicos/uso terapéutico , Prescripciones de Medicamentos , Administración Oral , Adolescente , Adulto , Anciano , Antibacterianos/uso terapéutico , Inhibidores de la Calcineurina/uso terapéutico , Niño , Preescolar , Bases de Datos Factuales , Emolientes/uso terapéutico , Femenino , Glucocorticoides/uso terapéutico , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Adulto Joven
6.
Pigment Cell Melanoma Res ; 31(2): 337-340, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29156497

RESUMEN

GATA2 deficiency is a recently described genetic disorder affecting hematopoietic stem cells and is associated with immunodeficiency, hematologic malignancy, and various cutaneous pathologies including cutaneous tumors. To explore the incidence and clinical course of melanoma in patients with germline GATA2 deficiencies, we conducted a retrospective chart review of 71 such patients and identified two with invasive melanoma. One melanoma was diagnosed early because it was associated with pruritus due to a graft-versus-tumor effect following bone marrow transplantation. The other one, a lentigo maligna melanoma, was locally excised but progressed to widespread metastasis and death several years later. Our observations and published studies of melanoma biology suggest an association between decreased GATA2 expression and melanoma progression. These findings suggest that GATA2 deficient patients may have an increased risk of melanoma and should be observed closely for new or changing skin lesions.


Asunto(s)
Factor de Transcripción GATA2/deficiencia , Melanoma/metabolismo , Femenino , Factor de Transcripción GATA2/metabolismo , Humanos , Melanoma/diagnóstico , Melanoma/patología , Modelos Biológicos , Factores de Riesgo
7.
Patient Prefer Adherence ; 10: 2091-2096, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27784999

RESUMEN

BACKGROUND: Adherence to acne medication is poor and is a major reason why treatment plans are ineffective. Recognizing solutions to nonadherence is critical. OBJECTIVE: The purpose of this study is to describe the hurdles associated with acne nonadherence and to provide mechanisms on how to ameliorate them. METHODS: PubMed database was searched. Of the 419 search results, 29 articles were reviewed to identify hurdles to adherence and corresponding solutions. RESULTS: Hurdles to primary nonadherence where the medication is not even started, include lack of knowledge, confusion about usage, weak physician-patient relationship, fear of adverse reactions, and cost. Secondary nonadherence hurdles where the medication is started but is not taken as directed include lack of results, complex regimens, side effects, busy lifestyle, forgetfulness, inconvenience, and psychiatric comorbidity. Solutions to these hurdles include treatment simplification, technology, and dynamic education. LIMITATIONS: Adherence is affected by numerous factors, but available literature analyzing acne adherence and interventions to improve adherence to treatment is limited. CONCLUSION: There are several hurdles in adhering to acne treatment. Recognition of these hurdles and finding appropriate solutions may be as important to treatment outcomes as choosing the right medication to prescribe.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA